The global immuno-oncology drugs market is expanding rapidly due to rising cancer prevalence and sustained clinical benefits.
Launches first Xenium application-focused panel optimized for immuno-oncology across all tissue types PLEASANTON, Calif., March 21, 2024 /PRNewswire/ -- 10x Genomics, Inc. (TXG) (Nasdaq: TXG), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results